SBIR/STTR Research Award

A Novel Engineered Composite Construct for Articular Cartilage Repair

Award identifier ba35b2a200cff180747e22e106f540994d9240ed652550a6ba73ceaf34ef3da9Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$222,759

Program and phase

SBIR · Phase I

Award year

2006

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Synthasome, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
U7HNMMTVDLN6
Solicitation number
PHS2006-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): There is a major clinical need for products to repair articular cartilage defects. The objective of this project is to develop a chondral repair device for articular cartilage that can be formed in vivo, and adheres to the surrounding host articular cartilage. The project uses two recently developed and complementary technologies that together have the potential to provide a mechanically functional and stable implant for articular cartilage repair. The intent of this Phase I project is to determine the feasibility of this product concept. The hypothesis for this proposal is that a composite construct with mechanical properties similar to native articular cartilage can be formed, adhered to native cartilage and provide an in situ articular chondral repair. To test the hypothesis three Specific Aims are proposed. Specific Aim 1. Optimize the composite construct to compressive and tensile properties of native human adult articular cartilage. Component variables will be assessed in a factorial study, to determine the optimal combination of biomaterials that provide tensile and compressive properties similar to native articular cartilage. Specific Aim 2. Optimize adherence of the composite construct to articular cartilage. Specific Aim 3. Demonstrate formation and attachment of the device in situ. The conditions identified in Aims 1 and 2 will be used to determine if the composite construct can be assembled within an articular defect in situ. The successful completion of this Phase I project will lead to a Phase II project, where the objective will be to determine safety and effectiveness of the device and method in vivo, using appropriate animal models. If successful, the data generated from these studies will be used in an IDE submission to the FDA to initiate a clinical trial.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

10 SBIR/STTR records share this UEI (2004–2012). Reported award amounts total $6,433,466. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.